Satoshi Kawashima
Osaka, 5450021, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Identification of severe hypoglycemia in adults with type 1 diabetes using CGM-based machine learning: evidence from the FGM-Japan study.
Journal: Diabetology international
Published: November 19, 2025
A machine learning approach to predicting severe diabetes distress in adults with type 1 diabetes mellitus.
Journal: Journal of diabetes investigation
Published: August 04, 2025
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Journal: Cardiovascular diabetology
Published: March 27, 2023
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial.
Journal: Diabetology international
Published: March 15, 2023
To Use or Not to Use a Self-monitoring of Blood Glucose System? Real-world Flash Glucose Monitoring Patterns Using a Cluster Analysis of the FGM-Japan Study.
Journal: Internal medicine (Tokyo, Japan)
Published: January 11, 2023
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study.
Journal: Journal of diabetes investigation
Published: October 27, 2022
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 21, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
Journal: Cardiovascular diabetology
Published: October 06, 2020
Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY).
Journal: Journal of diabetes science and technology
Published: August 09, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Journal: Cardiovascular diabetology
Published: April 06, 2020
Identification of human glycerophosphodiesterase 3 as an ecto phospholipase C that converts the G protein-coupled receptor 55 agonist lysophosphatidylinositol to bioactive monoacylglycerols in cultured mammalian cells.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: March 27, 2020
Last Updated: 09/26/2026